Annual ROE
-54.82%
-10.21%-22.89%
31 December 2023
Summary:
NextCure annual return on equity is currently -54.82%, with the most recent change of -10.21% (-22.89%) on 31 December 2023. During the last 3 years, it has fallen by -42.92% (-360.67%). NXTC annual ROE is now -186.51% below its all-time high of 63.37%, reached on 31 December 2017.NXTC ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-62.50%
-4.87%-8.45%
30 September 2024
Summary:
NextCure quarterly return on equity is currently -62.50%, with the most recent change of -4.87% (-8.45%) on 30 September 2024. Over the past year, it has dropped by -17.80% (-39.82%). NXTC quarterly ROE is now -228.68% below its all-time high of 48.57%, reached on 31 December 2018.NXTC Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NXTC ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.9% | -39.8% |
| 3 y3 years | -360.7% | -149.6% |
| 5 y5 years | -212.9% | -31.4% |
NXTC ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -360.7% | at low | -149.6% | at low |
| 5 y | 5 years | -212.9% | at low | -641.4% | at low |
| alltime | all time | -186.5% | at low | -228.7% | +39.0% |
NextCure ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -62.50%(+8.5%) |
| June 2024 | - | -57.63%(+8.1%) |
| Mar 2024 | - | -53.29%(+13.3%) |
| Dec 2023 | -54.82%(+22.9%) | -47.03%(+5.2%) |
| Sept 2023 | - | -44.70%(+2.2%) |
| June 2023 | - | -43.74%(+9.2%) |
| Mar 2023 | - | -40.05%(+2.0%) |
| Dec 2022 | -44.61%(+50.1%) | -39.27%(+9.2%) |
| Sept 2022 | - | -35.97%(+9.5%) |
| June 2022 | - | -32.85%(+7.2%) |
| Mar 2022 | - | -30.63%(+13.0%) |
| Dec 2021 | -29.73% | -27.10%(+8.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | -25.04%(+7.9%) |
| June 2021 | - | -23.20%(+10.9%) |
| Mar 2021 | - | -20.92%(+79.3%) |
| Dec 2020 | -11.90%(-51.6%) | -11.67%(+16.7%) |
| Sept 2020 | - | -10.00%(+18.6%) |
| June 2020 | - | -8.43%(-10.3%) |
| Mar 2020 | - | -9.40%(-68.2%) |
| Dec 2019 | -24.58%(-150.6%) | -29.54%(-37.9%) |
| Sept 2019 | - | -47.55%(-53.6%) |
| June 2019 | - | -102.41%(-313.0%) |
| Mar 2019 | - | 48.08%(-1.0%) |
| Dec 2018 | 48.57%(-23.4%) | 48.57% |
| Dec 2017 | 63.37% | - |
FAQ
- What is NextCure annual return on equity?
- What is the all time high annual ROE for NextCure?
- What is NextCure annual ROE year-on-year change?
- What is NextCure quarterly return on equity?
- What is the all time high quarterly ROE for NextCure?
- What is NextCure quarterly ROE year-on-year change?
What is NextCure annual return on equity?
The current annual ROE of NXTC is -54.82%
What is the all time high annual ROE for NextCure?
NextCure all-time high annual return on equity is 63.37%
What is NextCure annual ROE year-on-year change?
Over the past year, NXTC annual return on equity has changed by -10.21% (-22.89%)
What is NextCure quarterly return on equity?
The current quarterly ROE of NXTC is -62.50%
What is the all time high quarterly ROE for NextCure?
NextCure all-time high quarterly return on equity is 48.57%
What is NextCure quarterly ROE year-on-year change?
Over the past year, NXTC quarterly return on equity has changed by -17.80% (-39.82%)